Rybelsus is in a transition period in the US: Novo Nordisk says Rybelsus tablets are being replaced by Ozempic tablets. Patients currently taking Rybelsus should therefore verify both current Rybelsus coverage and the transition instructions before comparing longer-term costs.
Quick Answer
Novo Nordisk says Rybelsus is being replaced by Ozempic tablets and that patients need a new prescription to move to the new product. Current Rybelsus savings remain eligibility-based; NovoCare’s 2026 terms list eligible commercially insured patients with coverage as paying as little as $25, subject to maximum savings and dose-specific rules.
1. Check the Manufacturer Program First
The most important current manufacturer information is the product transition. NovoCare states that Rybelsus is being replaced by Ozempic tablets and that a new prescription is required to move products. NovoCare’s 2026 diabetes savings terms list eligible commercially insured patients with Rybelsus coverage as paying as little as $25, with maximum savings limits and dose-specific conditions. Full cash-paying patients are excluded from that savings offer.
Important
Manufacturer savings programs can have eligibility requirements and their terms can change. Check the current program directly before relying on a quoted saving or self-pay amount.
2. Compare the Same Prescription Across Pharmacies
Rybelsus is currently transitioning to Ozempic tablets, so verify the exact product on the prescription before comparing current pharmacy costs or savings terms. MediSearcher does not currently have an active commercial relationship with a Rybelsus pricing provider on this page.
When comparing prices, make sure you are looking at the same medication, strength, quantity and supply period. Insurance copays, pharmacy cash prices, discount prices and manufacturer programs are different payment routes and may not be directly comparable.
3. Re-check Insurance and Formulary Rules
For patients using insurance, current cost depends on coverage and the transition from Rybelsus to Ozempic tablets. Novo Nordisk says Ozempic tablets will have the same coverage as Rybelsus, but individual out-of-pocket costs still depend on the insurance plan.
4. Understand Online and Telehealth Access
Rybelsus and its replacement product require prescriptions. Patients considering online access should verify the exact product being prescribed and should not assume an old Rybelsus price or savings offer automatically applies to a new prescription.
Prescription required
Rybelsus is a prescription medication. A legitimate online or telehealth service should involve an appropriate evaluation by a licensed healthcare professional and should not guarantee a prescription before that evaluation.
5. If Rybelsus Is Still Unaffordable
If you currently use Rybelsus, discuss the manufacturer-announced transition with your prescriber before changing treatment. A new prescription is required to move to Ozempic tablets, and dose selection should be handled by the prescribing clinician.
Frequently Asked Questions
Is Rybelsus being discontinued or replaced?
Novo Nordisk currently states that Rybelsus is being replaced by Ozempic tablets. Patients moving to the new product need a new prescription.
Does Rybelsus have a savings offer in 2026?
Yes, but it is eligibility-based. NovoCare’s 2026 terms list eligible commercially insured patients with coverage as paying as little as $25, subject to maximum savings and dose-specific rules. Full cash-paying patients are excluded.
Should I switch from Rybelsus to Ozempic tablets myself?
No. Novo Nordisk says a new prescription is required. Discuss the transition and appropriate dose with the prescribing healthcare professional.
Sources and Verification
Pricing programs, eligibility requirements and medication access can change. MediSearcher checked the sources below on 17/09/2026. Verify current terms with the provider, manufacturer, pharmacy or insurer before purchasing.
Editorial note: MediSearcher does not rank providers according to commission payments. Prices, savings programs and availability should be independently verified because they can change.
Medical disclaimer: This page is for general informational and price-comparison purposes. It does not provide medical advice or recommend a particular medication. Consult a licensed healthcare professional before starting, stopping or changing prescription treatment.